News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Molecular Insight Pharmaceuticals, Inc. (MIPI) Mid-stage Cancer Drug, Onalta Trial Positive


4/13/2010 6:54:45 AM

Reuters -- Molecular Insight Pharmaceuticals Inc (MIPI.O) said data from a mid-stage trial of its cancer drug, Onalta, showed the drug improved symptoms associated with metastatic carcinoid tumors, sending its shares up 58 percent in post-market trade.

Read at Reuters
Read at Market Wired
Read at AP

comments powered by Disqus
Reuters
Market Wired
AP
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES